These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33273319)

  • 1. Therapeutic Perspectives and Mechanistic Insights of Phage Therapy in Allotransplantation.
    Dery KJ; Górski A; Międzybrodzki R; Farmer DG; Kupiec-Weglinski JW
    Transplantation; 2021 Jul; 105(7):1449-1458. PubMed ID: 33273319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota in organ transplantation: An immunological and therapeutic conundrum?
    Dery KJ; Kadono K; Hirao H; Górski A; Kupiec-Weglinski JW
    Cell Immunol; 2020 May; 351():104080. PubMed ID: 32139071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phages and their potential to modulate the microbiome and immunity.
    Federici S; Nobs SP; Elinav E
    Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage therapy: Current status and perspectives.
    Górski A; Międzybrodzki R; Węgrzyn G; Jończyk-Matysiak E; Borysowski J; Weber-Dąbrowska B
    Med Res Rev; 2020 Jan; 40(1):459-463. PubMed ID: 31062882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: bacteriophages in gastroenterology-from biology to clinical applications.
    Sabino J; Hirten RP; Colombel JF
    Aliment Pharmacol Ther; 2020 Jan; 51(1):53-63. PubMed ID: 31696976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease?
    Górski A; Jończyk-Matysiak E; Międzybrodzki R; Weber-Dąbrowska B; Borysowski J
    Front Immunol; 2018; 9():941. PubMed ID: 29755481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
    Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes?
    Fernández L; Duarte AC; Rodríguez A; García P
    Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption.
    Hesse S; Rajaure M; Wall E; Johnson J; Bliskovsky V; Gottesman S; Adhya S
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.
    Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785625
    [No Abstract]   [Full Text] [Related]  

  • 13. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and Characterization of Novel Phages Targeting Pathogenic
    Li N; Zeng Y; Bao R; Zhu T; Tan D; Hu B
    Front Cell Infect Microbiol; 2021; 11():792305. PubMed ID: 34926329
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
    Zurabov F; Zhilenkov E
    Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
    Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
    Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
    [No Abstract]   [Full Text] [Related]  

  • 20. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.